바이오 분석 시험 서비스 시장 분석 및 예측(-2035년) : 유형, 제품, 서비스, 기술, 용도, 프로세스, 최종 사용자, 기기, 솔루션, 모드

The global Bioanalytical Testing Services Market is projected to grow from $5.2 billion in 2025 to $12.5 billion by 2035, at a compound annual growth rate (CAGR) of 9.1%. The bioanalytical testing services market is driven by increasing drug development, stringent regulatory requirements, and growing demand for high-quality pharmacokinetic and biomarker analysis. According to the U.S. Food and Drug Administration (FDA) Office of Translational Sciences 2025 Annual Report, the FDA assessed more than 500 sites to support over 700 drug marketing applications and performed more than 200 site evaluations, including inspections of bioanalytical laboratories and Good Laboratory Practice (GLP) facilities. Rising regulatory oversight is driving demand for outsourced bioanalytical testing services.

The Type segment of the Bioanalytical Testing Services Market includes small molecule, large molecule, and others. Among these, small molecule testing holds a significant market share due to its extensive use in pharmaceutical development, clinical trials, and regulatory submissions. Small molecule bioanalysis involves evaluating drug concentration, pharmacokinetics, and pharmacodynamics to support safety and efficacy assessments. Large molecule testing is witnessing rapid growth due to the increasing development of biologics, monoclonal antibodies, vaccines, and advanced therapies requiring specialized analytical techniques. The growing adoption of precision medicine, biologics research, and advanced analytical platforms is driving demand for both small and large molecule bioanalytical testing services.

The Application segment of the Bioanalytical Testing Services Market includes oncology, neurology, cardiology, infectious diseases, immunology, and others. Oncology represents a leading application area due to the increasing number of cancer therapeutics, targeted therapies, and biologic drug candidates requiring extensive bioanalytical evaluation. Neurology and immunology applications are expanding with the development of complex therapies for neurological disorders and immune-related diseases. Infectious diseases continue to drive demand due to vaccine development and antiviral drug research, while cardiology applications benefit from increasing clinical research activities for cardiovascular therapies. Rising pharmaceutical R&D investments and growing clinical trial activities are further supporting market expansion across application areas.

Geographical Overview

North America held the largest share of the global bioanalytical testing services market in 2025, driven by its well-established pharmaceutical and biotechnology industries, advanced clinical research infrastructure, and high volume of drug development activities. The region is home to leading contract research organizations (CROs), biopharmaceutical companies, and analytical laboratories that provide bioanalytical testing for small molecules, biologics, biosimilars, cell and gene therapies, and vaccines. Increasing investments in precision medicine, growing clinical trial activity, and stringent regulatory requirements for pharmacokinetic, pharmacodynamic, and biomarker analyses have further strengthened market growth. Additionally, continuous advancements in mass spectrometry, ligand-binding assays, and laboratory automation reinforce North America's leadership in the global bioanalytical testing services market.

Asia Pacific is expected to witness the highest growth in the bioanalytical testing services market owing to expanding pharmaceutical and biotechnology research, increasing outsourcing of drug development activities, and growing investments in clinical trials. Countries such as China, India, South Korea, Japan, and Singapore are strengthening their research infrastructure through government support, expanding contract research organizations (CROs), and increasing biopharmaceutical manufacturing capabilities. Lower operational costs, availability of skilled scientific professionals, and rising demand for bioanalytical support in biologics, biosimilars, and cell and gene therapy development are further driving regional market expansion. Moreover, favorable regulatory reforms and increasing collaborations between global pharmaceutical companies and regional service providers are expected to position Asia Pacific as the fastest-growing regional market throughout the forecast period.

Key Trends and Drivers

Increasing Adoption of Advanced Bioanalytical Technologies and Biomarker-Based Testing:

The Bioanalytical Testing Services Market is witnessing a strong trend toward the adoption of advanced analytical technologies, including mass spectrometry, next-generation sequencing, immunoassays, and high-throughput testing platforms. Pharmaceutical and biotechnology companies are increasingly utilizing these services to support drug discovery, pharmacokinetic studies, biomarker identification, and clinical trial analysis. The growing complexity of biologics, biosimilars, cell therapies, and gene therapies is driving demand for specialized bioanalytical approaches with improved sensitivity and accuracy. Additionally, the integration of automation, artificial intelligence, and digital data management solutions is enhancing testing efficiency, reducing turnaround times, and improving regulatory compliance across drug development workflows.

Expanding Pharmaceutical R&D and Increasing Clinical Trial Activities:

The rapid expansion of pharmaceutical research and development activities is a major driver of the Bioanalytical Testing Services Market. The growing pipeline of small molecules, biologics, vaccines, and advanced therapies requires extensive bioanalytical testing to evaluate drug safety, efficacy, pharmacokinetics, and therapeutic performance. Increasing investments by pharmaceutical and biotechnology companies in clinical trials are creating higher demand for specialized testing services offered by contract research organizations (CROs). Furthermore, stringent regulatory requirements for drug approval and quality assessment are encouraging companies to outsource bioanalytical testing to experienced service providers. Rising healthcare innovation and the development of personalized medicines are further supporting market growth globally.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by End User
• 2.7 Key Market Highlights by Process
• 2.8 Key Market Highlights by Equipment
• 2.9 Key Market Highlights by Solutions
• 2.10 Key Market Highlights by Mode

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Small Molecule
  • 4.1.2 Large Molecule
  • 4.1.3 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Assay Kits
  • 4.2.2 Reagents
  • 4.2.3 Instruments
  • 4.2.4 Consumables
  • 4.2.5 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Pharmacokinetics
  • 4.3.2 Pharmacodynamics
  • 4.3.3 Bioavailability
  • 4.3.4 Bioequivalence
  • 4.3.5 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Chromatography
  • 4.4.2 Mass Spectrometry
  • 4.4.3 Nuclear Magnetic Resonance
  • 4.4.4 Electrophoresis
  • 4.4.5 Others
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Oncology
  • 4.5.2 Neurology
  • 4.5.3 Cardiology
  • 4.5.4 Infectious Diseases
  • 4.5.5 Immunology
  • 4.5.6 Others
• 4.6 Market Size & Forecast by End User (2020-2035)
  • 4.6.1 Pharmaceutical Companies
  • 4.6.2 Biotechnology Companies
  • 4.6.3 Contract Research Organizations
  • 4.6.4 Academic Institutes
  • 4.6.5 Others
• 4.7 Market Size & Forecast by Process (2020-2035)
  • 4.7.1 Preclinical
  • 4.7.2 Clinical
  • 4.7.3 Post-Market
  • 4.7.4 Others
• 4.8 Market Size & Forecast by Equipment (2020-2035)
  • 4.8.1 Liquid Chromatography
  • 4.8.2 Gas Chromatography
  • 4.8.3 Mass Spectrometers
  • 4.8.4 NMR Spectrometers
  • 4.8.5 Others
• 4.9 Market Size & Forecast by Solutions (2020-2035)
  • 4.9.1 Data Management
  • 4.9.2 Quality Assurance
  • 4.9.3 Regulatory Compliance
  • 4.9.4 Others
• 4.10 Market Size & Forecast by Mode (2020-2035)
  • 4.10.1 In-House
  • 4.10.2 Outsourced
  • 4.10.3 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 End User
    • 5.2.1.7 Process
    • 5.2.1.8 Equipment
    • 5.2.1.9 Solutions
    • 5.2.1.10 Mode
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 End User
    • 5.2.2.7 Process
    • 5.2.2.8 Equipment
    • 5.2.2.9 Solutions
    • 5.2.2.10 Mode
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 End User
    • 5.2.3.7 Process
    • 5.2.3.8 Equipment
    • 5.2.3.9 Solutions
    • 5.2.3.10 Mode
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 End User
    • 5.3.1.7 Process
    • 5.3.1.8 Equipment
    • 5.3.1.9 Solutions
    • 5.3.1.10 Mode
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 End User
    • 5.3.2.7 Process
    • 5.3.2.8 Equipment
    • 5.3.2.9 Solutions
    • 5.3.2.10 Mode
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 End User
    • 5.3.3.7 Process
    • 5.3.3.8 Equipment
    • 5.3.3.9 Solutions
    • 5.3.3.10 Mode
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 End User
    • 5.4.1.7 Process
    • 5.4.1.8 Equipment
    • 5.4.1.9 Solutions
    • 5.4.1.10 Mode
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 End User
    • 5.4.2.7 Process
    • 5.4.2.8 Equipment
    • 5.4.2.9 Solutions
    • 5.4.2.10 Mode
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 End User
    • 5.4.3.7 Process
    • 5.4.3.8 Equipment
    • 5.4.3.9 Solutions
    • 5.4.3.10 Mode
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 End User
    • 5.4.4.7 Process
    • 5.4.4.8 Equipment
    • 5.4.4.9 Solutions
    • 5.4.4.10 Mode
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 End User
    • 5.4.5.7 Process
    • 5.4.5.8 Equipment
    • 5.4.5.9 Solutions
    • 5.4.5.10 Mode
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 End User
    • 5.4.6.7 Process
    • 5.4.6.8 Equipment
    • 5.4.6.9 Solutions
    • 5.4.6.10 Mode
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 End User
    • 5.4.7.7 Process
    • 5.4.7.8 Equipment
    • 5.4.7.9 Solutions
    • 5.4.7.10 Mode
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 End User
    • 5.5.1.7 Process
    • 5.5.1.8 Equipment
    • 5.5.1.9 Solutions
    • 5.5.1.10 Mode
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 End User
    • 5.5.2.7 Process
    • 5.5.2.8 Equipment
    • 5.5.2.9 Solutions
    • 5.5.2.10 Mode
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 End User
    • 5.5.3.7 Process
    • 5.5.3.8 Equipment
    • 5.5.3.9 Solutions
    • 5.5.3.10 Mode
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 End User
    • 5.5.4.7 Process
    • 5.5.4.8 Equipment
    • 5.5.4.9 Solutions
    • 5.5.4.10 Mode
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 End User
    • 5.5.5.7 Process
    • 5.5.5.8 Equipment
    • 5.5.5.9 Solutions
    • 5.5.5.10 Mode
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 End User
    • 5.5.6.7 Process
    • 5.5.6.8 Equipment
    • 5.5.6.9 Solutions
    • 5.5.6.10 Mode
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 End User
    • 5.6.1.7 Process
    • 5.6.1.8 Equipment
    • 5.6.1.9 Solutions
    • 5.6.1.10 Mode
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 End User
    • 5.6.2.7 Process
    • 5.6.2.8 Equipment
    • 5.6.2.9 Solutions
    • 5.6.2.10 Mode
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 End User
    • 5.6.3.7 Process
    • 5.6.3.8 Equipment
    • 5.6.3.9 Solutions
    • 5.6.3.10 Mode
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 End User
    • 5.6.4.7 Process
    • 5.6.4.8 Equipment
    • 5.6.4.9 Solutions
    • 5.6.4.10 Mode
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 End User
    • 5.6.5.7 Process
    • 5.6.5.8 Equipment
    • 5.6.5.9 Solutions
    • 5.6.5.10 Mode

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Charles River Laboratories
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Eurofins Scientific
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 SGS SA
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Labcorp
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 WuXi AppTec
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Pace Analytical Services
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Intertek Group
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 PPD Inc
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Covance Inc
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 ICON plc
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Syneos Health
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Medpace Holdings
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Frontage Laboratories
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Q2 Solutions
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Almac Group
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 BioAgilytix Labs
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Pharmaceutical Product Development LLC
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Envigo
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Toxikon Corporation
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Altasciences
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us